Parexel: Growing need to communicate with assorted stakeholders drives medical writing service offering

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Gajus)
(Image: Getty/Gajus)
Parexel’s new medical writing solutions offering will provide communications services throughout the drug development and commercialization process to help sponsors meet higher documentation quality standards, says VP.

According to the Waltham, MA-based contract research organization (CRO), the medical writing solutions team is made up of more than 800 experts around the globe.

“We have seen the drug development journey continue to evolve, with advancements in trial design and technology, changing regulatory requirements, and the growing need to communicate effectively to a multi-faceted audience, including investigators, patients, agencies, and authorities,”​ said Julia Cooper, vice president, head of global medical writing solutions at Parexel.

“As a result, biopharmaceutical companies must have access to highly-experienced medical writers who can communicate with all stakeholders in an integrated way through each critical stage of development and commercialization,”​ she told us.

Cooper explained the new offering will ensure an integrated and streamlined communications strategy across the drug development and commercialization continuum.

“In order to meet product development and commercialization demands, biopharmaceutical companies are increasingly being held to a higher standard of quality documentation,”​ she added.

Earlier this month, Parexel announced​ the appointment of its new CEO, Jamie Macdonald. The company also recently partnered with BioFortis​ to offer biological sample lifecycle management services.  

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars